RSS   Newsletter   Contact   Advertise with us

Genus appoints two non-executive directors

Staff Writer | Basingstoke, United Kingdom | May 25, 2018
GenusGenus, an animal genetics company announced the appointments of Lesley Knox and Ian Charles to the board as non-executive directors, with effect from June 1, 2018 and July 1, 2018 respectively.
Lesley Knox brings a wealth of international, strategic and financial services experience.

Ms. Knox has held several Non-Executive Directorships and is currently Non-Executive Director and Chair of the Remuneration Committee at Legal & General Group plc, Non-Executive Director for Thomas Cook Group plc, and also Chair of Grosvenor Group.

She previously served on the Board of both Centrica plc and SAB Miller plc as Non-Executive Director and Chair of the Remuneration Committee.

Ms. Knox spent over 17 years in corporate finance with Kleinwort Benson and then as a founder director of British Linen Advisers.

She was also head of institutional asset management at Kleinwort Benson and has advised a wide range of companies which included manufacturers and distributors of food products including poultry and poultry breeding companies.

Ian Charles is Director of the Quadram Institute, Norwich, UK and was previously Director of the ithree institute, University of Technology, Sydney, Australia.

An entrepreneurial scientist, Mr. Charles is co-founder and Board Director of Auspherix, and was co-founder and CSO of Arrow Therapeutics.

Mr. Charles's current research focus is in the area of infectious diseases, the microbiome, and its impact on health and well-being.

He has over 30 years' experience in academic and commercial research organisations, including The Wolfson Institute for BioMedical Research at University College London and Glaxo Wellcome.

 LATEST MOVES FROM United Kingdom